Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer
Clinical trial NCT02154737 · COMPLETED
Trial details
- NCT number
- NCT02154737
- Sponsor
- Tony Reid, M.D., Ph.D.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2020-09-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.